Find investors
← Back to all investors
AK
ResearchedAngel Investors

Anurag Kumar

CFO

Angel InvestorsSeed Round
Pitch Anurag

Get their honest, personalized take on your startup.

Sign in to pitch Anurag

At a glance

Full Name
Anurag Kumar
Title
Chief Financial Officer (CFO)
Firm
Jacob Ballas Capital India Private Limited
Firm Type
Private equity advisory / growth-equity investment firm (NBFC). *(Note: the stub described "Angel Investors / Seed Round," but Jacob Ballas is an institutional growth-equity firm, not an angel network.)*
Investment Stage
Growth equity / late-stage (commonly described as Series B and beyond)
Check Size
~US$10–50 million per investment (firm-level)
Target Company Profile
Established, profitable or scaling private companies seeking growth capital, typically with a 3–5 year horizon and exit via strategic sale or IPO
Sector Focus
Healthcare & diagnostics, financial services & fintech, consumer/retail, media & entertainment, and infrastructure/industrial real estate
Geographic Focus
India
Location
New Delhi, India (Commercial Plaza, Mahipalpur, National Highway 8)

Background

Anurag Kumar is the Chief Financial Officer of Jacob Ballas Capital India Private Limited, a New Delhi–based private equity advisory firm founded in 1995. As CFO he sits within the firm's management team alongside leaders such as Srinivas Chidambaram (Managing Director & CEO) and partner Sunil Chawla, and is responsible for the firm's finance, fund administration, and financial-control functions across the India-focused funds it advises. His firm email ([hidden]) and the New Delhi head-office line (91-11-4315-3100) are consistent across business directories and the firm's own contact details.

Jacob Ballas Capital acts as the advisor to the investment managers of three India-dedicated private equity funds with more than US$600 million under management: the New York Life International India Fund (~US$40M), the New York Life Investment Management India Fund (~US$127M), and NYLIM Jacob Ballas India Fund III (~US$440M). The firm is owned by its founding/management team together with New York Life Investment Management, which holds roughly a 25% stake. The firm describes its team of "professionals turned entrepreneurs" as having over 150 years of collective industry experience, including more than 80 years specifically in private equity advisory.

In a private equity firm of this structure, the CFO's mandate centers on fund-level finance, investor reporting, regulatory compliance for the NBFC, valuation oversight, and the financial governance of portfolio transactions and exits — rather than on sourcing deals. Public records consistently list Anurag Kumar's single, current senior role as CFO at Jacob Ballas; detailed prior-career and education specifics are not reliably documented in public sources and are therefore not asserted here.

Investment Thesis & Focus

  • Growth-stage, not seed/angel: The firm provides growth capital to established Indian companies — typical tickets of roughly US$10–50 million, an investment horizon of about 3–5 years, and exits via strategic sale or IPO.
  • Diversified, India-only mandate: Investments span healthcare and diagnostics, financial services and fintech, consumer/retail, media & entertainment, payments, and industrial/real-estate infrastructure.
  • Long-cycle institutional capital: As advisor to closed-end New York Life–backed funds, the firm backs companies it can support through a multi-year value-creation cycle and an eventual liquidity event.
  • CFO's role in the thesis: Anurag Kumar's contribution is on the financial-diligence, structuring, fund-administration, and exit-execution side rather than as a deal-originating partner — relevant context for how a founder would actually engage the firm.

Notable Investments

  • Super Religare Laboratories (SRL) / Agilus Diagnostics — Diagnostics chain; Jacob Ballas India Fund and the IFC together invested ~Rs 370 crore (~US$66M); the diagnostics business later operated as Agilus Diagnostics.
  • Religare Finvest — ~Rs 200 crore investment into Religare Enterprises' NBFC arm; the firm recorded an exit from Religare Enterprises on 20-Feb-2025.
  • FSS (Financial Software & Systems) — Chennai-based payments processor (investment ~2014); investors including Jacob Ballas explored exits around 2024.
  • Imagicaa — Mumbai-area theme-park/entertainment operator (investment ~2014).
  • Inventia Healthcare — Pharmaceutical formulations company; exited around 2018–19 (around the time of an IPO filing).
  • Crocodile menswear — Consumer/apparel holding; exit realized ~2018–19.
  • Centrum Capital (forex business) — Investment ~2017 alongside New York Life Investments.
  • Lifeline Laboratory / CBIG Consulting — Healthcare diagnostics and IT-consulting portfolio names cited in deal databases.
  • Cerestra industrial real-estate fund — June 2019 partnership to establish an industrial/warehousing real-estate vehicle.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.